Certified by Founder Lodge
Blue Owl Capital
United States - New York
INVESTOR
1 Disclosed Funding Rounds $200,000,000
10 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Blue Owl Capital (NYSE: OWL) is a global alternative asset manager with more than $138 billion in assets under management as of December 31, 2022. Anchored by a strong permanent capital base,
Company | Date | Round | Raised |
---|---|---|---|
Mirador Therapeutics | March, 26 ,2024 | Unknown | $400,000,000 |
CloudPay | August, 09 ,2024 | Unknown | $120,000,000 |
Axonius | March, 08 ,2022 | Series E | $200,000,000 |
6sense | January, 20 ,2022 | Series E | $200,000,000 |
Alterome Therapeutics, Inc | April, 09 ,2024 | Series B | $132,000,000 |
Vestwell | December, 21 ,2023 | Unknown | $125,000,000 |
CloudPay | August, 09 ,2024 | Unknown | $120,000,000 |
Mirador Therapeutics | March, 26 ,2024 | Unknown | $400,000,000 |
Alterome Therapeutics, Inc | April, 09 ,2024 | Series B | $132,000,000 |
CloudPay | August, 09 ,2024 | Unknown | $120,000,000 |